Event

Warp Sciences Emerges from Stealth with $215 Million in Funding

1 reports · 1 sources

Warp Sciences emerged from stealth last week, securing $215 million in funding. The company says it will build a chemistry contract research organization (CRO) located in the United States, combining chemists, robots, and AI to synthesize and test molecules for research teams. Warp Sciences says its initial services will focus on analog synthesis in lead compound optimization—that is, making molecular variants for scientists to compare as they search for drug candidates. Its laboratory will be progressively automated through robots and AI, with experienced chemists guiding experiments and AI models trained on data generated by physical experiments. Warp Sciences says the company itself has no proprietary drug pipeline; instead, it designs automated laboratories capable of running experiments, learning from them, and improving round by round.